Literature DB >> 7506579

Increased viral titer through concentration of viral harvests from retroviral packaging lines.

R W Paul1, D Morris, B W Hess, J Dunn, R W Overell.   

Abstract

Dependent on the viral vector and the specific assay used, viral titers produced from commonly used retroviral packaging cell lines have an upper limit in the range of 10(5) to 10(7) infectious units/ml. We have developed a generally applicable method, using hollow-fiber filtration technology, which allows for the concentration of infectious virus derived from packaging lines. This method resulted in a reproducible 10- to 30-fold increase in viral titer and can readily be scaled to accommodate larger input volumes. Over 80% of the input virus is recovered in an infectious form in the concentrate. Concentrated virus containing media was seen to produce higher infection frequencies in Jurkat T cells as compared to unconcentrated virus containing media; however, this was not proportional to the differences in viral titer observed by limiting dilution analysis on NIH-3T3 cells. These results are discussed in relation to the importance of factors other than viral titer in determining transduction frequencies.

Mesh:

Substances:

Year:  1993        PMID: 7506579     DOI: 10.1089/hum.1993.4.5-609

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  15 in total

1.  Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours.

Authors:  S T Andreadis; D Brott; A O Fuller; B O Palsson
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Proteoglycans secreted by packaging cell lines inhibit retrovirus infection.

Authors:  J M Le Doux; J R Morgan; R G Snow; M L Yarmush
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

3.  A rapid and efficient method for concentration of small volumes of retroviral supernatant.

Authors:  D L Miller; P J Meikle; D S Anson
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

4.  Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296.

Authors:  E C MacNeill; H Hanenberg; K E Pollok; J C van der Loo; M F Bierhuizen; G Wagemaker; D A Williams
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway.

Authors:  L J Katen; M M Januszeski; W F Anderson; K J Hasenkrug; L H Evans
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  Complementation cell lines for viral vectors to be used in gene therapy.

Authors:  M Mehtali
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

7.  Retrovirus infection: effect of time and target cell number.

Authors:  J R Morgan; J M LeDoux; R G Snow; R G Tompkins; M L Yarmush
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Tagging retrovirus vectors with a metal binding peptide and one-step purification by immobilized metal affinity chromatography.

Authors:  Kaiming Ye; Sha Jin; Mohammad M Ataai; Jerome S Schultz; Jeanette Ibeh
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Optimization of environmental factors for the production and handling of recombinant retrovirus.

Authors:  S G Lee; S Kim; P D Robbins; B G Kim
Journal:  Appl Microbiol Biotechnol       Date:  1996-05       Impact factor: 4.813

10.  Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection.

Authors:  S Andreadis; T Lavery; H E Davis; J M Le Doux; M L Yarmush; J R Morgan
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.